Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;26(3):366-375.
doi: 10.1158/1055-9965.EPI-16-0496. Epub 2016 Nov 3.

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers

Affiliations

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers

S Ghazaleh Dashti et al. Cancer Epidemiol Biomarkers Prev. 2017 Mar.

Abstract

Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive.Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer.Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and >28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09-2.07 and 1.69; 95% CI, 1.07-2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27-2.49 and 1.94; 95% CI, 1.19-3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk.Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers.Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366-75. ©2016 AACR.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The authors have no conflict of interest to declare with respect to this manuscript.

Figures

Figure 1
Figure 1. Hazard ratios for associations between alcohol consumption and the risk of colon, rectum, and colorectal cancer for DNA mismatch repair gene germline mutation carriers by sex
Abbreviations: HR, hazard ratio; CI, confidence interval; PY, person-years All models were multivariable and adjusted for country (categorical, time-fixed), education (categorical, time-fixed l), ascertainment (binary, time-fixed), at age 20 (categorical, time-fixed), diabetes status (binary, time-varying), regular physical activity (binary, time-varying), and smoking status (categorical, time-varying) Models for women were additionally adjusted for number of live births (categorical, time-varying), and years of hormonal contraceptive use (categorical, time-varying) Models for beer were additionally adjusted for average daily ethanol intake from wine (binary, time-varying) and from spirits (binary, time-varying) Models for wine were additionally adjusted for average daily ethanol intake from beer (binary, time-varying) and from spirits (binary, time-varying) Models for sake were additionally adjusted for average daily ethanol intake from beer (binary, time-varying) and from wine (binary, time-varying)

References

    1. Jass JR. Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. World J Gastroenterol. 2006;12:4943–50. - PMC - PubMed
    1. Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer. 2015;15:181–94. - PubMed
    1. Boland CR, Shike M. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. Gastroenterology. 2010;139:2197 e1–7. - PMC - PubMed
    1. Hampel H, de la Chapelle A. The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means? Cancer Prev Res. 2011;4:1–5. - PMC - PubMed
    1. Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304–10. - PubMed

Publication types

MeSH terms